“Runner Up: Incidence of Cutaneous Adverse Events with PI3K-Akt-mTOR Pathway Inhibitors: A Systematic Review and Network Meta-Analysis”, J of Skin, vol. 6, no. 3, p. s39, May 2022, doi: 10.25251/skin.6.supp.39.